Curated News
By: NewsRamp Editorial Staff
July 17, 2026
SS Innovations Appoints New CFO to Drive Global Robotic Surgery Expansion
TLDR
- SS Innovations gains an experienced CFO who raised over $100 million, positioning it for FDA clearance and global expansion.
- Sarah Romano joins as CFO effective August 3, bringing 20+ years of medtech finance experience to support SSi Mantra regulatory and international growth.
- SS Innovations trains 33 healthcare professionals from 7 countries, advancing global access to robotic surgery and improving patient outcomes.
- The SSi Mantra robotic system aims to make surgery more precise, with surgeon training programs now graduating doctors worldwide.
Impact - Why it Matters
This news matters because SS Innovations is advancing robotic surgery technology that could transform patient outcomes globally. The appointment of a seasoned CFO with a track record of raising capital and managing public-company finances signals that the company is gearing up for significant milestones, including potential FDA clearance for its SSi Mantra system. If successful, this could lead to more affordable and accessible robotic surgery options, impacting healthcare costs and surgical precision. The company's focus on training surgeons through SSICRS also addresses a critical gap in adoption, ensuring that technology deployment is paired with skilled practitioners. For investors and patients alike, this development represents a step toward broader availability of innovative surgical solutions.
Summary
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medtech finance executive Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. Her appointment comes as SS Innovations continues pursuing U.S. FDA clearance for its SSi Mantra surgical robotic system while expanding internationally. The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program, which welcomed 33 healthcare professionals from seven countries, underscoring the company’s emphasis on surgeon education alongside technology deployment. Romano joins SS Innovations after serving as CFO at Vicarious Surgical, where she oversaw financial and operational initiatives to reduce cash burn and strengthen the balance sheet. This strategic hire signals the company’s readiness for the next phase of growth as it prepares for FDA review and broader commercialization.
The appointment highlights SS Innovations’ focus on strengthening its leadership team to support its global expansion and regulatory milestones. The SSi Mantra surgical robotic platform is at the core of the company’s strategy, and the recent SSICRS training program reflects its commitment to ensuring surgeons are well-prepared to use the technology. With Romano’s expertise in capital markets and public-company finance, she is expected to play a key role in driving the company’s financial strategy and supporting its mission to make robotic surgery accessible worldwide. The company’s newsroom at https://nnw.fm/SSII provides the latest updates. For more details, read the full release at Read More>>.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Appoints New CFO to Drive Global Robotic Surgery Expansion
